Ardsley Advisory Partners’s Boston Scientific BSX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q4
Sell
-2,000
Closed -$81K 154
2019
Q3
$81K Buy
+2,000
New +$84.7K 0.02% 125

Other funds holding BSX

Ardsley Advisory Partners's BSX Position: Q2 2026 in Review

Ardsley Advisory Partners sold out of Boston Scientific (BSX) in Q2 2026, closing a stake of 150,000 shares — an estimated $9.41M sold.

Ardsley Advisory Partners first reported a position in BSX in Q4 2013 and held it in 21 quarters. The position peaked at $9.41M in Q1 2026. 425 funds tracked by Wall St. Rank hold BSX as of Q2 2026.

  • Ardsley Advisory Partners reported no remaining Boston Scientific position as of Q2 2026 after selling out during the quarter.
  • Ardsley Advisory Partners sold 150,000 Boston Scientific shares in Q2 2026, an estimated $9.41M.
  • Ardsley Advisory Partners first reported a position in Boston Scientific in Q4 2013 and held it in 21 quarters.
  • Ardsley Advisory Partners's Boston Scientific position peaked at $9.41M in Q1 2026.
  • 425 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.

Based on Ardsley Advisory Partners's 13F filing for Q2 2026, filed 13 Jul 2026.